The multifunctional influenza virus protein PB1-F2 plays several roles in deregulation of host innate immune responses and is a known immunopathology enhancer of the 1918 influenza pandemic. Here, we show that the 1918 PB1-F2 protein not only interferes with the mitochondria-dependent pathway of type I interferon (IFN) signaling, but also acquired a novel IFN antagonist function by targeting the DEAD-box helicase DDX3, a key downstream mediator in antiviral interferon signaling, toward proteasome-dependent degradation. Interactome analysis revealed that 1918 PB1-F2, but not PR8 PB1-F2, binds to DDX3 and causes its co-degradation. Consistent with intrinsic protein instability as basis for this gain-of-function, internal structural disorder is associated with the unique cytotoxic sequences of the 1918 PB1-F2 protein. Infusing mice with recombinant DDX3 protein completely rescued them from lethal infection with the 1918 PB1-F2-producing virus. Alongside NS1 protein, 1918 PB1-F2 therefore constitutes a potent IFN antagonist causative for the severe pathogenicity of the 1918 influenza strain. Our identification of molecular determinants of pathogenesis should be useful for the future design of new antiviral strategies against influenza pandemics.
Co-degradation of interferon signaling factor DDX3 by PB1-F2 as a basis for high virulence of 1918 pandemic influenza.
PB1-F2 与干扰素信号因子 DDX3 的共降解是 1918 年大流行性流感病毒高毒力的基础
阅读:3
作者:Park Eun-Sook, Byun Young Ho, Park Soree, Jang Yo Han, Han Woo-Ry, Won Juhee, Cho Kyung Cho, Kim Doo Hyun, Lee Ah Ram, Shin Gu-Choul, Park Yong Kwang, Kang Hong Seok, Sim Heewoo, Ha Yea Na, Jae Byeongjune, Son Ahyun, Kim Paul, Yu Jieun, Lee Hye-Min, Kwon Sun-Bin, Kim Kwang Pyo, Lee Seung-Hyun, Park Yeong-Min, Seong Baik L, Kim Kyun-Hwan
| 期刊: | EMBO Journal | 影响因子: | 8.300 |
| 时间: | 2019 | 起止号: | 2019 May 15; 38(10):e99475 |
| doi: | 10.15252/embj.201899475 | 研究方向: | 信号转导 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
